Le Lézard
Classified in: Environment, Science and technology
Subject: TDS

Minesto presents today at Naventus Renewables Summit, Stockholm


GOTHENBURG, Sweden, March 26, 2024 /PRNewswire/ -- Minesto's CEO Dr Martin Edlund presents today at Naventus Renewables Summit held in Stockholm, 26 March 2024.  

The event is livestreamed, and Minesto will be presenting at 14.40 CET: 

 Naventus & Partners Renewables Summit 2024

For additional information, please contact

Cecilia Sernhage, Chief Communications Officer
+46 735 23 71 58
[email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/minesto-ab/r/minesto-presents-today-at-naventus-renewables-summit--stockholm,c3952237

SOURCE Minesto AB


These press releases may also interest you

at 00:45
Claudio Bono, Managing Director for two independent Hotels in Silicon Valley, is thrilled to unveil a groundbreaking platform and an idea that will transform the landscape of the urgent unhoused crisis and social issues. Leveraging his extensive...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

26 avr 2024
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...



News published on and distributed by: